Market Overview:
The global molecular diagnostic instrument market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for personalized medicine, and technological advancements in molecular diagnostics instruments. Based on type, the global molecular diagnostic instrument market is segmented into nucleic acid extractor, PCR instrument, nucleic acid molecule hybridization instrument, gene chip instrument, and genetic sequencer. The PCR instruments segment is expected to account for the largest share of the global molecular diagnostic instrument market in 2018. This segment is also projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to its high adoption rate across various applications such as hospital laboratories and clinics. Based on application, the global molecular diagnostic instrument market is divided into hospital laboratories, clinic laboratories (including point-of-care testing), and research institutes/academic institutions segments. The hospital laboratory segment accounted for majority share of revenue generated by this market in 2017 owing to rising number of hospitals worldwide coupled with increasing demand for advanced diagnostics tests such as next-generation sequencing (NGS).
Product Definition:
A molecular diagnostic instrument is a device used to detect and identify molecules in a sample. This type of instrument is important for diagnosing diseases, especially those that are caused by genetic abnormalities.
Nucleic Acid Extractor:
Nucleic acid extractor is a device used for isolation and purification of nucleic acids. It's major applications are in molecular diagnostic instrument market. The nucleic acid extractors available in the global market vary in size, complexity, capacity and price.
PCR Instrument:
Polymerase Chain Reaction (PCR) is a technique that uses DNA as a probe to identify and amplify specific genetic sequences. The technology was developed in the early 1990s by the Japanese physician/biotechnologist, Dr. Kaynakai Hata, for detection of gene-specific amplification products in clinical samples.
Application Insights:
The hospital application segment dominated the global molecular diagnostic instrument market in 2017. This can be attributed to factors such as presence of a large number of hospitals, clinics and laboratories with advanced diagnostics capabilities. Moreover, an increase in the prevalence of chronic diseases such as cancer across various regions is expected to drive demand for molecular diagnostic tests over the forecast period.
Clinical diagnosis involves detection and identification of disease states at an early stage when treatment is most effective. Molecular testing offers advantages including improved sensitivity over traditional methods due to which it has been gaining popularity among clinicians worldwide. Increasing adoption of these instruments at clinical level coupled with rising awareness about their benefits are anticipated to fuel revenue growth during the forecast period.
Molecular diagnostics finds wide applications in laboratory settings including research laboratories, government agencies and public health systems, pharmaceutical companies etc., owing to its effectiveness in detecting & identifying infectious diseases along with other chronic disorders that affect human health globally.
Regional Analysis:
North America dominated the global molecular diagnostic instruments market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing prevalence of cancer and other chronic diseases. Moreover, government initiatives promoting early diagnosis are expected to fuel regional growth during the forecast period. For instance, in February 2016 ‘Cancer Biomarkers Training Program’ was launched by U.S Department of Health & Human Services (HHS).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with growing health awareness among people from developing countries such as India and China.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in molecular diagnostics instruments
- Growing number of private and public sector funding for molecular diagnostics research
- Increasing awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Diagnostic Instrument Market Research Report
By Type
Nucleic Acid Extractor, PCR Instrument, Nucleic Acid Molecule Hybridization Instrument, Gene Chip Instrument, Genetic Sequencer
By Application
Hospital, Clinic, Laboratory
By Companies
Illumina, ThermoFisher, Roche, DAAN Gene, BGI Group, Agilent Technologies, QIAGEN, Macrogen, ELITech Group, Analytik Jena, Bio-Rad, Promega, Texas BioGene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Diagnostic Instrument Market Report Segments:
The global Molecular Diagnostic Instrument market is segmented on the basis of:
Types
Nucleic Acid Extractor, PCR Instrument, Nucleic Acid Molecule Hybridization Instrument, Gene Chip Instrument, Genetic Sequencer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- ThermoFisher
- Roche
- DAAN Gene
- BGI Group
- Agilent Technologies
- QIAGEN
- Macrogen
- ELITech Group
- Analytik Jena
- Bio-Rad
- Promega
- Texas BioGene
Highlights of The Molecular Diagnostic Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nucleic Acid Extractor
- PCR Instrument
- Nucleic Acid Molecule Hybridization Instrument
- Gene Chip Instrument
- Genetic Sequencer
- By Application:
- Hospital
- Clinic
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Diagnostic Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A molecular diagnostic instrument is a laboratory tool that uses chemical or biological analysis to identify the presence of specific molecules in a sample. Molecular diagnostics can be used to diagnose diseases, assess the effectiveness of treatments, and monitor the health of patients.
Some of the major companies in the molecular diagnostic instrument market are Illumina, ThermoFisher, Roche, DAAN Gene, BGI Group, Agilent Technologies, QIAGEN, Macrogen, ELITech Group, Analytik Jena, Bio-Rad, Promega, Texas BioGene.
The molecular diagnostic instrument market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Molecular Diagnostic Instrument Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Molecular Diagnostic Instrument Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Molecular Diagnostic Instrument Market - Supply Chain
4.5. Global Molecular Diagnostic Instrument Market Forecast
4.5.1. Molecular Diagnostic Instrument Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Molecular Diagnostic Instrument Market Size (000 Units) and Y-o-Y Growth
4.5.3. Molecular Diagnostic Instrument Market Absolute $ Opportunity
5. Global Molecular Diagnostic Instrument Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Molecular Diagnostic Instrument Market Size and Volume Forecast by Type
5.3.1. Nucleic Acid Extractor
5.3.2. PCR Instrument
5.3.3. Nucleic Acid Molecule Hybridization Instrument
5.3.4. Gene Chip Instrument
5.3.5. Genetic Sequencer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Molecular Diagnostic Instrument Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Molecular Diagnostic Instrument Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Laboratory
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Molecular Diagnostic Instrument Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Molecular Diagnostic Instrument Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Molecular Diagnostic Instrument Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Molecular Diagnostic Instrument Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Molecular Diagnostic Instrument Demand Share Forecast, 2019-2026
9. North America Molecular Diagnostic Instrument Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Molecular Diagnostic Instrument Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Molecular Diagnostic Instrument Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Laboratory
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Molecular Diagnostic Instrument Market Size and Volume Forecast by Type
9.7.1. Nucleic Acid Extractor
9.7.2. PCR Instrument
9.7.3. Nucleic Acid Molecule Hybridization Instrument
9.7.4. Gene Chip Instrument
9.7.5. Genetic Sequencer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Molecular Diagnostic Instrument Demand Share Forecast, 2019-2026
10. Latin America Molecular Diagnostic Instrument Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Molecular Diagnostic Instrument Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Molecular Diagnostic Instrument Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Laboratory
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Molecular Diagnostic Instrument Market Size and Volume Forecast by Type
10.7.1. Nucleic Acid Extractor
10.7.2. PCR Instrument
10.7.3. Nucleic Acid Molecule Hybridization Instrument
10.7.4. Gene Chip Instrument
10.7.5. Genetic Sequencer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Molecular Diagnostic Instrument Demand Share Forecast, 2019-2026
11. Europe Molecular Diagnostic Instrument Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Molecular Diagnostic Instrument Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Molecular Diagnostic Instrument Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Laboratory
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Molecular Diagnostic Instrument Market Size and Volume Forecast by Type
11.7.1. Nucleic Acid Extractor
11.7.2. PCR Instrument
11.7.3. Nucleic Acid Molecule Hybridization Instrument
11.7.4. Gene Chip Instrument
11.7.5. Genetic Sequencer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Molecular Diagnostic Instrument Demand Share, 2019-2026
12. Asia Pacific Molecular Diagnostic Instrument Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Molecular Diagnostic Instrument Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Molecular Diagnostic Instrument Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Laboratory
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Molecular Diagnostic Instrument Market Size and Volume Forecast by Type
12.7.1. Nucleic Acid Extractor
12.7.2. PCR Instrument
12.7.3. Nucleic Acid Molecule Hybridization Instrument
12.7.4. Gene Chip Instrument
12.7.5. Genetic Sequencer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Molecular Diagnostic Instrument Demand Share, 2019-2026
13. Middle East & Africa Molecular Diagnostic Instrument Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Molecular Diagnostic Instrument Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Molecular Diagnostic Instrument Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Laboratory
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Molecular Diagnostic Instrument Market Size and Volume Forecast by Type
13.7.1. Nucleic Acid Extractor
13.7.2. PCR Instrument
13.7.3. Nucleic Acid Molecule Hybridization Instrument
13.7.4. Gene Chip Instrument
13.7.5. Genetic Sequencer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Molecular Diagnostic Instrument Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Molecular Diagnostic Instrument Market: Market Share Analysis
14.2. Molecular Diagnostic Instrument Distributors and Customers
14.3. Molecular Diagnostic Instrument Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Illumina
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ThermoFisher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DAAN Gene
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BGI Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Agilent Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. QIAGEN
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Macrogen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ELITech Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Analytik Jena
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bio-Rad
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Promega
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Texas BioGene
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook